DNTH vs MOS · rev $6.2M vs P/E 161, rev $11.12B
Dianthus Therapeutics Inc. (DNTH) versus The Mosaic Company (MOS) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
The Mosaic Company (MOS) is a agricultural inputs company listed on US.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported MOS revenue for 2024-12-31 was $11.12B. Net income was $202.0M. Revenue was down 18.8% from 2023-12-31 to 2024-12-31. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
DNTH currently screens at market cap $4.40B. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
Not investment advice. Open the DNTH and MOS stock pages for the full models.
Not investment advice.